Company Filing History:
Years Active: 2021-2023
Title: Innovations of Ting-Chun Hung
Introduction
Ting-Chun Hung is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody-drug conjugates. With a total of 2 patents, his work is recognized for its potential impact on targeted cancer therapies.
Latest Patents
Ting-Chun Hung's latest patents focus on antibody-drug conjugates (ADCs). One of his patents describes an ADC with a structure represented by Formula (I): a pharmaceutically acceptable salt thereof wherein Ab is an antibody without glycans, and various moieties are defined for drug units and linkers. Another patent also details an ADC structure, emphasizing the innovative design that enhances therapeutic efficacy.
Career Highlights
Ting-Chun Hung is currently associated with Cho Pharma Inc., where he continues to advance his research in the pharmaceutical industry. His work is pivotal in the development of new treatments that leverage the specificity of antibodies to deliver drugs directly to cancer cells.
Collaborations
Ting-Chun Hung has collaborated with notable colleagues, including Nan-Horng Lin and Charng-Sheng Tsai. These partnerships have fostered a collaborative environment that enhances the innovation process within their projects.
Conclusion
Ting-Chun Hung's contributions to the field of antibody-drug conjugates exemplify the importance of innovation in pharmaceuticals. His patents reflect a commitment to advancing cancer treatment methodologies.